BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36934378)

  • 1. Does Stage Migration Occur as a Consequence of Omitting Completion Lymph Node Dissection for Melanoma?
    Senders ZJ; Bartlett EK; Mouw TJ; McMasters KM; Egger ME
    Ann Surg Oncol; 2023 Jun; 30(6):3648-3654. PubMed ID: 36934378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Completion lymph node dissection in patients with sentinel lymph node positive cutaneous head and neck melanoma.
    Huang K; Misra S; Lemini R; Chen Y; Speicher LL; Dawson NL; Tolaymat LM; Bagaria SP; Gabriel EM
    J Surg Oncol; 2020 Nov; 122(6):1057-1065. PubMed ID: 32654173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omission of Completion Lymph Node Dissection in Sentinel Node Biopsy Positive Head and Neck Cutaneous Melanoma Patients.
    Kesmodel SB; Kronenfeld JP; Zhao W; Koru-Sengul T; Goel N; Weingrad DN; Hernandez-Aya L; Lutzky J; Feun L; Garland-Kledzik M; Crystal JS
    Ann Surg Oncol; 2023 Nov; 30(12):7671-7685. PubMed ID: 37639029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.
    Lee DY; Lau BJ; Huynh KT; Flaherty DC; Lee JH; Stern SL; O'Day SJ; Foshag LJ; Faries MB
    J Am Coll Surg; 2016 Jul; 223(1):9-18. PubMed ID: 27236435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage IIIa Melanoma and Impact of Multiple Positive Lymph Nodes on Survival.
    Woeste MR; McMasters KM; Egger ME
    J Am Coll Surg; 2021 Apr; 232(4):517-524.e1. PubMed ID: 33316426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National Practice Patterns in the Management of the Regional Lymph Node Basin After Positive Sentinel Lymph Node Biopsy for Cutaneous Melanoma.
    Sharon CE; Straker RJ; Li EH; Karakousis GC; Miura JT
    Ann Surg Oncol; 2022 Dec; 29(13):8456-8464. PubMed ID: 36006494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States.
    Bilimoria KY; Balch CM; Bentrem DJ; Talamonti MS; Ko CY; Lange JR; Winchester DP; Wayne JD
    Ann Surg Oncol; 2008 Jun; 15(6):1566-76. PubMed ID: 18414952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life after axillary or groin sentinel lymph node biopsy, with or without completion lymph node dissection, in patients with cutaneous melanoma.
    de Vries M; Hoekstra HJ; Hoekstra-Weebers JE
    Ann Surg Oncol; 2009 Oct; 16(10):2840-7. PubMed ID: 19639366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of the positive sentinel lymph node in the post-MSLT-II era.
    Bredbeck BC; Mubarak E; Zubieta DG; Tesorero R; Holmes AR; Dossett LA; VanKoevering KK; Durham AB; Hughes TM
    J Surg Oncol; 2020 Dec; 122(8):1778-1784. PubMed ID: 32893366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Completion Lymph Node Dissection Based on Risk of Nonsentinel Metastasis in Cutaneous Melanoma of the Head and Neck.
    Fritsch VA; Cunningham JE; Lentsch EJ
    Otolaryngol Head Neck Surg; 2016 Jan; 154(1):94-103. PubMed ID: 26399717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma sentinel lymph node biopsy and completion lymph node dissection: A regional hospital experience.
    Williams TS; Tallon B; Adams BM
    J Plast Reconstr Aesthet Surg; 2022 Feb; 75(2):730-736. PubMed ID: 34789434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of prognostic factors for non-sentinel lymph node metastasis in patients undergoing sentinel lymph node biopsy for cutaneous malignant melanoma: Experience from a reference centre in Turkey.
    Yalcin CE; Melenkis S; Demir L; Okur FT; Sagir MS; Ercan A
    J Plast Reconstr Aesthet Surg; 2024 Apr; 91():167-172. PubMed ID: 38417393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Completion node dissection in patients with sentinel node-positive melanoma of the head and neck.
    Smith VA; Cunningham JE; Lentsch EJ
    Otolaryngol Head Neck Surg; 2012 Apr; 146(4):591-9. PubMed ID: 22237296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma.
    Masoud SJ; Perone JA; Farrow NE; Mosca PJ; Tyler DS; Beasley GM
    Curr Treat Options Oncol; 2018 Sep; 19(11):55. PubMed ID: 30232648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National practice patterns of completion lymph node dissection for sentinel node-positive melanoma.
    Hewitt DB; Merkow RP; DeLancey JO; Wayne JD; Hyngstrom JR; Russell MC; Gerami P; Balch CM; Bilimoria KY
    J Surg Oncol; 2018 Sep; 118(3):493-500. PubMed ID: 30098302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).
    Broman KK; Hughes T; Dossett L; Sun J; Kirichenko D; Carr MJ; Sharma A; Bartlett EK; Nijhuis AAG; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; Frank J; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Farma JM; Deneve JL; Fleming MD; Perez MC; Lowe MC; Olofsson Bagge R; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras J; Teras RM; Farrow NE; Beasley G; Hui JYC; Been L; Kruijff S; Kim Y; Naqvi SMH; Sarnaik AA; Sondak VK; Zager JS
    Cancer; 2021 Jul; 127(13):2251-2261. PubMed ID: 33826754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Outcomes Between Surveillance Ultrasound and Completion Lymph Node Dissection in Children and Adolescents With Sentinel Lymph Node-Positive Cutaneous Melanoma.
    Scoville SD; Stanek JR; Rinehardt H; Sutthatarn P; Abdelhafeez AH; Talbot LJ; Malek M; Leraas HJ; Tracy ET; Chen SY; Kim ES; Lotakis DM; Ehrlich PF; Favela JG; Le HD; Davidson J; Wilson CA; Seemann NM; Osman Y; Piche N; Hoang V; Petroze RT; Polites SF; McKay KG; Correa H; Lovvorn HN; Lee YM; Balagani A; Dasgupta R; Aldrink JH
    Ann Surg; 2024 Mar; 279(3):536-541. PubMed ID: 37487006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma.
    Guggenheim MM; Hug U; Jung FJ; Rousson V; Aust MC; Calcagni M; Künzi W; Giovanoli P
    Ann Surg; 2008 Apr; 247(4):687-93. PubMed ID: 18362633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma.
    Gyorki DE; Boyle JO; Ganly I; Morris L; Shaha AR; Singh B; Wong RJ; Shah JP; Busam K; Kraus D; Coit DG; Patel S
    Eur J Surg Oncol; 2014 Mar; 40(3):305-10. PubMed ID: 24361245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers.
    Broman KK; Hughes TM; Bredbeck BC; Sun J; Kirichenko D; Carr MJ; Sharma A; Bartlett EK; Nijhuis AAG; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; O'shea K; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Hotz M; Farma JM; Deneve JL; Fleming MD; Perez M; Baecher K; Lowe M; Bagge RO; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras J; Teras RM; Farrow NE; Beasley GM; Hui JYC; Been L; Kruijff S; Sinco B; Sarnaik AA; Sondak VK; Zager JS; Dossett LA;
    Ann Surg; 2023 May; 277(5):e1106-e1115. PubMed ID: 35129464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.